Prime Capital Investment Advisors, LLC Recursion Pharmaceuticals, Inc. Transaction History
Prime Capital Investment Advisors, LLC
- $6.88 Billion
- Q3 2024
A detailed history of Prime Capital Investment Advisors, LLC transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Prime Capital Investment Advisors, LLC holds 10,167 shares of RXRX stock, worth $72,795. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,167
Previous 10,178
0.11%
Holding current value
$72,795
Previous $76,000
11.84%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding RXRX
# of Institutions
297Shares Held
242MCall Options Held
1.35MPut Options Held
2.32M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl32.8MShares$235 Million2.05% of portfolio
-
Baillie Gifford & CO25.2MShares$181 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA24.3MShares$174 Million0.0% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$124 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA15.4MShares$110 Million1.41% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.29B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...